Healthcare >> Analyst Interviews >> June 28, 2012

Hospital Volumes are Stabilizing Amidst Reimbursement Uncertainties

Gallucci, Thomas
Thomas Gallucci is a Managing Director and Senior Analyst covering health care services at Lazard Capital Markets. Before joining Lazard Capital in May 2009, he worked at Merrill Lynch for 10 years, primarily focused on the health care distribution and pharmacy benefit management subsectors, the health care facilities space and the retail drug business. In 2008, Mr. Gallucci had the honor of being named to the Institutional Investor All-America team in two categories, health care distribution/technology and health care facilities. Similarly, he was named to the Institutional Investor All-America team every year from 2004 to 2008 in the health care distribution/technology category, and in 2003 was designated by Institutional Investor as one of the top Up and Coming analysts on the Street. Mr. Gallucci also has consistently ranked in the top tier of the Greenwich Associates survey in the health care distribution category. As an indicator of his stockpicking abilities, he placed fourth in The Wall Street Journal Best on the Street 2008 Analyst Survey, and was named one of eight Institutional Investor Home-Run Hitters in 2001. Mr. Gallucci began his career in health care services equity research in 1995 at Credit Suisse First Boston, and worked at Bear Stearns from 1996 to 1999. Before that, he worked at Ernst & Young. He holds a B.S. in accounting from Lehigh University. Profile
TWST: Please set the stage with an overview of your coverage universe.

Mr. Gallucci: From a high level, we tend to divide our coverage into two broad subsectors. One would be services